CRISPR-Cas9-based genome-editing technologies in engineering bacteria for the production of plant-derived terpenoids
Engineering Microbiology · 2024-09 · 4 (3) · 100154
DOI: 10.1016/j.engmic.2024.100154 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Engineering Microbiology, 2024-09. Verfasst von Xin Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Biosynthesis of Natural Products, CAMS Key Labor…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Nova Program, Chinese Academy of Meteorological Sciences.
Abstract (Originalsprache)
Terpenoids are widely used as medicines, flavors, and biofuels. However, the use of these natural products is largely restricted by their low abundance in native plants. Fortunately, heterologous biosynthesis of terpenoids in microorganisms offers an alternative and sustainable approach for efficient production. Various genome-editing technologies have been developed for microbial strain construction. Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 (Cas9) is the most commonly used system owing to its outstanding efficiency and convenience in genome editing. In this review, the basic principles of CRISPR-Cas9 systems are briefly introduced and their applications in engineering bacteria for the production of plant-derived terpenoids are summarized. The aim of this review is to provide an overview of the current developments of CRISPR-Cas9-based genome-editing technologies in bacterial engineering, concluding with perspectives on the challenges and opportunities of these technologies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, NHC Key Laboratory of Biosynthesis of Natural Products, CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs, Institute of Materi…
- Shandong Academy of Pharmaceutical Sciences, Jinan 250101, China.
Förderung
- Beijing Nova Program
- Chinese Academy of Meteorological Sciences
Zitieren
APA
Sun, X., Zhang, H., Jia, Y., Li, J., & Jia, M. (2024). CRISPR-Cas9-based genome-editing technologies in engineering bacteria for the production of plant-derived terpenoids. Engineering Microbiology, 4(3), 100154. https://doi.org/10.1016/j.engmic.2024.100154
Vancouver
Sun X, Zhang H, Jia Y, Li J, Jia M. CRISPR-Cas9-based genome-editing technologies in engineering bacteria for the production of plant-derived terpenoids. Engineering Microbiology. 2024;4(3):100154. doi:10.1016/j.engmic.2024.100154
BibTeX
@article{Sun2024,
author = {Sun, Xin and Zhang, Haobin and Jia, Yuping and Li, Jingyi and Jia, Meirong},
title = {CRISPR-Cas9-based genome-editing technologies in engineering bacteria for the production of plant-derived terpenoids},
journal = {Engineering Microbiology},
year = {2024},
volume = {4},
number = {3},
pages = {100154},
doi = {10.1016/j.engmic.2024.100154}
}
EUVIMED